Global Hypertension Drugs Market 2014-2018
Published on: April 2014 No. of Pages: 65 Mail us: sales@reportsandintelligence.com Detailed report at: http://www.reportsandintelligence.com/globalhypertension-drugs-2014-2018-market Website: http://www.reportsandintelligence.com
Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking are the major causes of hypertension. Hypertension can damage organs and lead to several illnesses such as renal failure, aneurysm, heart failure, stroke, and heart attack. There are two types of hypertension: primary or essential and secondary. TechNavio's analysts forecast the Global Hypertension Drugs market will grow at a CAGR of 1.2 percent over the period 2013-2018. Covered in this Report The Global Hypertension Drugs market can be categorized into eight segments: Diuretics, ACE Inhibitors, ARBs, CCB, Beta Blockers, Alpha Blockers, Vasodilators, and Renin Inhibitors. To calculate the market size, the report considers the revenue generated from the sales of various hypertension drugs used in the treatment of pulmonary arterial hypertension and essential hypertension. TechNavio's report, the Global Hypertension Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Hypertension Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Key Regions • Americas • EMEA • APAC Key Vendors • Actelion Ltd. • AstraZeneca plc • Boehringer Ingelheim GmbH • Novartis AG • Pfizer Inc. • Sanofi SA
Other Prominent Vendors • Bayer AG • Daiichi Sankyo Co. Ltd. • Forest Laboratories Inc. • Merck & Co. Inc. • Takeda Pharmaceutical Co. Ltd. • United Therapeutics Corp. • Valeant Pharmaceuticals International Inc. • XOMA LLC Key Market Driver • Increase in Aging Population. • For a full, detailed list, view our report. Key Market Challenge • Increasing Number of Patent Expirations. • For a full, detailed list, view our report. Key Market Trend • Increasing Focus on Combination Therapies. • For a full, detailed list, view our report. Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
Detailed report at: http://www.reportsandintelligence.com/globalhypertension-drugs-2014-2018-market
Table of Content 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Market Landscape 06.1 Market Overview 06.2 Market Size and Forecast 06.3 Five Forces Analysis 07. Rate of Incidence and Prevalence 07.1.1 Americas 07.1.2 The APAC Region 07.1.3 Europe 08. Late Stage Pipeline Snapshot 09. Market Segmentation by Mechanism of Action 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 18.1 Competitive Scenario 18.1.1 Key News 18.1.2 Mergers and Acquisitions 18.2 Market Share Analysis 2013 18.3 Other Prominent Vendors
19. Key Vendor Analysis 19.1 Actelion Ltd. 19.1.1 Business Overview 19.1.2 Key Information 19.1.3 SWOT Analysis 19.2 AstraZeneca plc 19.2.1 Business Overview 19.2.2 Key Information 19.2.3 SWOT Analysis 19.3 Boehringer Ingelheim GmbH 19.3.1 Business Overview 19.3.2 Business Segmentation 19.3.3 Key Information 19.3.4 SWOT Analysis 19.4 Novartis AG 19.4.1 Business Overview 19.4.2 Business Segmentation 19.4.3 Key Information 19.4.4 SWOT Analysis 19.5 Pfizer Inc. 19.5.1 Business Overview 19.5.2 Business Segmentation 19.5.3 Key Information 19.5.4 SWOT Analysis 19.6 Sanofi SA 19.6.1 Business Overview 19.6.2 Business Segmentation 19.6.3 Key Information 19.6.4 SWOT Analysis 20. Other Reports in this Series
Full TOC at: http://www.reportsandintelligence.com/global-hypertensiondrugs-2014-2018-market/table-of-contents
Contact Us: Cathy Viber 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct: +1 (617) 674-4143 Toll Free: +1 (855) 711-1555 Fax: +1 (855) 550-5975 Mailto: sales@reportsandintelligence.com Web: http://www.reportsandintelligence.com/ Blog: http://www.reportsandintelligence.blogspot.com/